Skip to main content

Table 1 Subject characteristics

From: Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts

Cohort AD cases Controls (N)
  N Age at onset APOEε2/ε3/ε4 N Age at exam APOEε2/ε3/ε4
   (mean ± SD) (allele %)   (mean ± SD) (allele %)
ACT 566 83.90 (4.8) 0.05 / 0.69 / 0.26 1696 81.08 (6.0) 0.08 / 0.81 /0.11
ADC1 1566 72.47 (7.1) 0.03 / 0.55 / 0.42 515 75.00 (8.0) 0.08 / 0.76 / 0.16
ADC2 738 73.19 (7.1) 0.03 / 0.57 / 0.39 160 75.68 (7.9) 0.09 / 0.75 / 0.16
ADNI 268 75.30 (7.2) 0.03 / 0.55 / 0.42 173 78.6 (5.5) 0.08 / 0.79 / 0.14
GenADA 669 74.59 (6.2) 0.04 / 0.58 / 0.38 713 74.21 (7.0) 0.08 / 0.79 / 0.13
MIAMI 1186 74.06 (7.8) 0.03 / 0.61 / 0.36 1135 74.00 (8.3) 0.08 / 0.80 / 0.12
MIRAGE 509 71.16 (6.5) 0.04 / 0.60 / 0.36 753 72.04 (7.2) 0.06 / 0.72 / 0.23
NIA-LOAD 1811 73.57 (6.7) 0.02 / 0.51 / 0.46 1575 73.99 (8.5) 0.07 / 0.73 / 0.20
OHSU 132 86.10 (5.5) 0.07 / 0.70 / 0.23 153 83.86 (7.6) 0.10 / 0.82 / 0.08
TGEN 864 74.91 (7.2) 0.04 / 0.57 / 0.40 493 80.19 (8.7) 0.10 / 0.79 / 0.11
TOTAL 8309 -- -- 7366 -- --